This is a narrative review synthesizing scientific literature on antimicrobial resistance mechanisms and treatment approaches, offering expert perspective rather than reporting original trial data or clinical evidence.
This is a mechanistic screening study identifying a microbial metabolite and its in vitro antimicrobial properties; it raises a question about potential therapeutic synergy rather than testing an intervention in a clinical or translational trial.
This is an early-stage chemical synthesis and in vitro screening study with no animal or clinical data; it raises the question whether these compounds merit further development but does not yet answer whether they are safe or effective in disease.